GenturaDx   www.progentech.com
凱晟生物科技有限公司成立于2005年5月，坐落在美國高科技研發(fā)中心——硅谷。是由數(shù)位在分子生物學(xué)、生物化學(xué)、微電子學(xué)、市場營銷學(xué)方面的專家創(chuàng)建而成，專業(yè)致力于核酸蛋白純化等分子診斷領(lǐng)域。公司于2008年3月成功融資2100萬美元。
公司的第一個(gè)產(chǎn)品Entura 全自動(dòng)核酸蛋白純化系統(tǒng)于2008年通過UL、CE驗(yàn)證。目前，已經(jīng)通過直銷或者經(jīng)銷的方式全面銷售。
在硅谷、上海各團(tuán)隊(duì)的領(lǐng)導(dǎo)下，凱晟生物科技有限公司將為生命科學(xué)、分子診斷領(lǐng)域提供最優(yōu)質(zhì)的產(chǎn)品和服務(wù)。

ProGenTech 是一家位于上海、蘇州和加州 Emeryville 的生命科學(xué)與診斷公司。該公司成立于2005年，如今擁有員工80名。該公司首個(gè)產(chǎn)品 Entura 于2007年11月在亞洲推出。

ProGenTech 改名為GenturaDx 
2012年Luminex收購分子診斷公司GenturaDx

ProGenTech Limited is a life science and molecular diagnostics company committed to developing next generation instrumentation for nucleic acid and protein purification and molecular diagnostic testing. The company was founded in 2005 and has offices in the San Francisco Bay Area and Shanghai.
The company’s proprietary Entura Lite instrument is a simple and efficient sample preparation platform designed to increase efficiency in the lab through true walk away automation. The Entura Lite is compatible with the company’s unique disposable cassettes, which carry all the reagents onboard that are required to isolate a variety of nucleic acids and proteins from a variety of sample types.
The Entura Lite platform and disposable cassette serves as the foundation for ProGenTech’s fully-integrated instrument for molecular diagnostic testing that is currently under development. The initial diagnostic assays for use on the integrated system will be specific to detecting hospital-acquired infection targets.